Paola Magnaghi
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer therapeutics and mechanisms, Protease and Inhibitor Mechanisms, Sarcoma Diagnosis and Treatment
Most-Cited Works
- → Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death(2013)381 cited
- → Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications(2016)312 cited
- → Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor(2016)295 cited
- → HIRA, a mammalian homologue of Saccharomyces cerevisiae transcriptional co-repressors, interacts with Pax3(1998)167 cited
- → Crystal Structures of Anaplastic Lymphoma Kinase in Complex with ATP Competitive Inhibitors(2010)165 cited
- → The TPM3‐NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition(2014)152 cited
- → Alkylsulfanyl-1,2,4-triazoles, a New Class of Allosteric Valosine Containing Protein Inhibitors. Synthesis and Structure–Activity Relationships(2012)91 cited
- → Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury(2017)88 cited
- → Anaplastic Lymphoma Kinase: Role in specific tumours, and development of small molecule inhibitors for cancer therapy(2010)55 cited
- → Ten allelic apolipoprotein[a] 5' flanking fragments exhibit comparable promoter activities in HepG2 cells.(1995)44 cited